about
Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitmentComparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection.HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance.Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.Effectiveness of HPV vaccination in women reaching screening age in Italy.Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women.Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology.Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix.HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.Technical evaluation of the new thin layer device CellSlide (Menarini Diagnostics).Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult bloodScreening for colorectal cancer by faecal occult blood test: comparison of immunochemical testsReproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening SettingComparing conventional and liquid-based smears from a consecutive series of 297 subjects referred to colposcopy assessmentTriage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessmentAssociation of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsiesReproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening SettingComparison of the conventional cervical smear and liquid-based cytology: results of a controlled, prospective study in the Abruzzo Region of ItalyMolecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis
P50
Q33596805-323EBD52-A5EF-45ED-A656-70880291238EQ35066980-E5AB5FF7-1B1B-486B-AB81-C034D52BBEAEQ35690377-03793F98-D6C0-4F81-A521-76D24E541EC0Q37265745-263F65B6-2E35-4329-82BB-CBE20AA98C30Q38599101-9B61652E-8793-4E26-8917-8CE6AF1C6306Q38669823-9D02E8C3-C59B-44BC-B91B-BE63C0ECCA4DQ38733634-A5DE1609-F575-430C-AA0C-FFB7EAC827ECQ39302372-5A5ED8AB-7CA4-44D0-8AF5-011E9715D15FQ40251694-81D1E493-0431-46B9-AF77-AA955CBFEDEBQ40358326-0882E83D-7F18-48F0-A926-318EAA6DDBE6Q41548112-C6804F3B-6FE0-44B2-B4B8-D73089AC92D4Q41651390-833618EE-1D06-464B-8E28-DE696EC93464Q44119126-B845ACD6-A68C-406C-A531-438B23FB9BE8Q49907625-FCEE3EEE-3515-4C9B-B8FB-1A8D47FAE1D2Q51201676-DAF7ED63-71CD-4A5D-BBEB-0FAAABD37672Q51317040-B5CD35EA-3D34-462F-BE0C-C1B65DCB5E84Q51547564-92EA28D6-E2FD-4B9D-A7BB-8F19C13F9E9DQ59193671-377F6076-9BDE-4AED-BDD4-90E5F79BDBF1Q59193674-9A82C094-EAC6-4C77-A529-B644D073CA29Q63966441-0A22B29C-B95D-476B-8695-725463E0D253Q80138555-BDA793DF-BE2B-400B-91A2-612A62CF1542Q81129212-ACA63F5A-8CED-4D3F-A3B5-96C65C94D8A3Q81262405-C1B9896B-DF00-4C07-A004-0811BD1C1765Q81306581-18159B88-9CF7-4721-984F-41AAA4B4658EQ82200410-1D9F8ACD-07FF-4BF2-9850-8719D11F6FD0Q84330504-6668942F-4E99-4EE7-8EFE-FCC9081FDB00
P50
description
researcher ORCID ID = 0000-0001-8955-8913
@en
wetenschapper
@nl
name
Cristina Sani
@ast
Cristina Sani
@en
Cristina Sani
@es
Cristina Sani
@nl
type
label
Cristina Sani
@ast
Cristina Sani
@en
Cristina Sani
@es
Cristina Sani
@nl
prefLabel
Cristina Sani
@ast
Cristina Sani
@en
Cristina Sani
@es
Cristina Sani
@nl
P106
P1153
6701663264
8286749700
P21
P31
P496
0000-0001-8955-8913